Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Jul 19, 2026
Automatic Data Processing (ADP) Surges +16.9% Over 30 Days on Earnings Momentum

Automatic Data Processing (ADP) Surges +16.9% Over 30 Days on Earnings Momentum

Key Takeaways

  • ADP shares surged approximately 16.9% over the 30-day period through mid-July 2026, climbing from $218.41 on June 18 to $255.27 on July 17.
  • The rally was fueled by upbeat analyst revisions, a $9.2 billion credit facility expansion, strong institutional buying, and growing optimism ahead of the July 29 fiscal Q4 earnings report.
  • Over the last quarter, ADP delivered a roughly 27% gain, rebounding sharply from its 52-week low of $188.16 set on April 10, 2026, following a powerful Q3 earnings beat in late April.
  • AI-driven productivity gains, record client retention, and Lyric HCM adoption momentum have strengthened the bull case for ADP's human capital management platform.
  • Consensus analyst rating remains Hold with an average price target of approximately $248.64, suggesting the stock may already reflect much of the near-term upside.

ADP's Established Position in Human Capital Management

Automatic Data Processing, Inc. is one of the world's largest providers of cloud-based human capital management (HCM) solutions, serving over one million clients across 140 countries. Headquartered in Roseland, New Jersey, and founded in 1949, ADP operates through two primary segments: Employer Services and Professional Employer Organization (PEO) Services. Its flagship platforms—RUN Powered by ADP, ADP Workforce Now, and the next-generation ADP Lyric HCM—cover payroll, HR, talent management, benefits administration, compliance, and workforce analytics. With a market capitalization exceeding $102 billion, a 27-year streak of consecutive annual dividend increases, and a beta of 0.83, ADP is widely regarded as a defensive, dividend-growing stalwart within the business services and payroll processing industry. Investors follow the stock closely for its recurring revenue model, client retention metrics, and sensitivity to U.S. employment trends.

ADP Stock Performance: The Last 30 Days and the Broader Quarter

Over the 30 calendar days ending July 17, 2026, ADP shares climbed from a closing price of $218.41 on June 18 to $255.27 on July 17—a gain of approximately 16.9%. The move represented a dramatic acceleration from the prior month, during which the stock had briefly dipped to an interim low of $214.60 on June 22. The rally unfolded in two distinct legs: a recovery from the late-June trough into the $235–$242 range by early July, followed by a breakout during the week of July 13 that pushed shares as high as $261.31 intraday on July 17. Volume spiked notably on several sessions, including 8.66 million shares on June 26 and above-average activity during the July breakout, indicating strong institutional participation. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Zooming out to the quarterly view, the stock's performance is even more striking. From a closing price of $200.47 on April 17, 2026, ADP rallied roughly 27% over the subsequent three months. The quarterly story is defined by a sharp V-shaped recovery: the stock hit its 52-week low of $188.16 on April 10 amid broader market pressure, only to reverse powerfully after reporting fiscal Q3 2026 earnings on April 29 that beat consensus estimates on both revenue ($5.94 billion) and adjusted EPS ($3.37). That earnings-driven gap-up of roughly 8% in a single session reset the stock's trajectory and laid the foundation for the sustained advance that followed through May, June, and July.

Catalysts Behind the Recent 30-Day Advance

Several tangible catalysts converged to drive ADP's 30-day surge. On July 8, Stifel raised its price target on ADP to $260 from $240, citing positive key performance indicators and strong results from peer PAYX, which reported in late June. Stifel projected fiscal 2027 client float income approximately $90 million above consensus, representing a roughly 30-basis-point margin tailwind. The following day, Wells Fargo lifted its target from $214 to $248, adding further momentum.

In late June, ADP entered into new revolving credit agreements totaling $9.2 billion—comprising a $5.7 billion 364-day facility and a $3.5 billion five-year facility—significantly boosting the company's liquidity and financial flexibility for working capital needs and potential acquisitions. Institutional activity also turned bullish: Wealthfront Advisers LLC disclosed a 25.8% increase in its ADP stake in Q1, while Center for Wealth Management Advisory established a new position of nearly 7,000 shares valued at approximately $1.41 million.

Anticipation around ADP's fiscal Q4 2026 earnings report, scheduled for July 29, further fueled the rally. Analysts project Q4 EPS of $2.59, up 14.6% year-over-year, with full-year fiscal 2026 EPS of $11.08. ADP has beaten Wall Street EPS estimates in each of the last four quarters, and management's raised full-year guidance for 6–7% revenue growth and 70–80 basis points of adjusted EBIT margin expansion has reinforced confidence heading into the report.

Quarterly Drivers and Operational Momentum

The broader quarterly narrative centers on ADP's fiscal Q3 2026 earnings report on April 29, which served as the definitive inflection point. The company posted revenue of $5.94 billion and adjusted EPS of $3.37, both comfortably exceeding analyst estimates. More importantly, management raised full-year guidance across revenue, margin, and EPS, citing strong retention rates, AI-driven operational productivity, and robust international bookings. The announcement triggered an 8% single-day rally and initiated a multi-month uptrend.

Underpinning the quarterly performance were measurable efficiency gains from ADP's AI investments. During the Q3 call, management reported that ADP Assist saved payroll agents an average of 30 minutes per payroll run, Smart Actions reduced clicks by roughly 80% for common HR tasks, and internal AI deployments cut year-end processing volumes by approximately 35%. Record third-quarter client satisfaction scores and employer services retention rates further solidified the investment thesis. On the capital allocation front, ADP continued repurchasing shares at elevated levels while raising its quarterly dividend to $1.70 per share—the 27th consecutive annual increase—reinforcing the stock's appeal to income-oriented investors.

Exploring AI-Powered Trading Approaches

For traders seeking data-driven approaches to navigate moves like ADP's recent rally, Tickeron's Trending AI Robots page offers a curated selection of AI-powered trading bots. Tickeron hosts hundreds of AI-driven bots that collectively trade thousands of tickers, but only the top-performing and most relevant strategies appear in this regularly updated section. These bots employ varied methodologies—including swing trading, trend following, and pattern recognition—across different timeframes and performance metrics, allowing users to explore AI-generated trading signals tailored to their preferred style. Whether you are monitoring ADP or scanning the broader market, the Trending AI Robots page provides a streamlined entry point into AI-assisted trading. In my view, this kind of tool can help put recent price action into a broader context when used alongside traditional analysis.

What to Watch as ADP Approaches Earnings

The most immediate catalyst is ADP's fiscal Q4 2026 earnings release on July 29. Beyond the headline numbers, investors should pay close attention to fiscal 2027 guidance—particularly revenue growth assumptions, PEO worksite employee projections, client funds interest income forecasts, and margin expansion targets. Stifel's projection of 5.5% Employer Services growth and 5.5% PEO growth for fiscal 2027, slightly below consensus on PEO, suggests that any upside or downside relative to these benchmarks could move the stock.

Macroeconomic variables remain critical. ADP's business is closely tied to U.S. employment levels, wage growth, and small-to-midsize business health. Any deterioration in labor market conditions or blue-collar employment trends would introduce headwinds. Conversely, continued strength in job creation and wage inflation would support pays-per-control growth and client funds balances. Interest rate expectations also matter: higher rates boost ADP's float income, while a rapid cutting cycle could compress those tailwinds. Competitive dynamics in the HCM space—particularly around AI-enabled platforms—and ADP's ability to convert Lyric HCM momentum into sustained market share gains represent additional factors worth monitoring. I’m watching this closely as the earnings date approaches.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: ADP

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


ADP in +1.56% Uptrend, advancing for three consecutive days on August 04, 2026

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where ADP advanced for three days, in of 320 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for ADP just turned positive on July 28, 2026. Looking at past instances where ADP's MACD turned positive, the stock continued to rise in of 47 cases over the following month. The odds of a continued upward trend are .

The 50-day moving average for ADP moved above the 200-day moving average on July 30, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

The Aroon Indicator entered an Uptrend today. In of 259 cases where ADP Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for ADP moved out of overbought territory on August 07, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 34 similar instances where the indicator moved out of overbought territory. In of the 34 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 68 cases where ADP's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ADP declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

ADP broke above its upper Bollinger Band on July 28, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (17.730) is normal, around the industry mean (28.479). P/E Ratio (24.619) is within average values for comparable stocks, (81.364). Projected Growth (PEG Ratio) (2.498) is also within normal values, averaging (1.725). Dividend Yield (0.025) settles around the average of (0.048) among similar stocks. P/S Ratio (4.948) is also within normal values, averaging (69.517).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ADP’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock slightly better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to slightly better than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

Notable companies

The most notable companies in this group are Shopify Inc (NASDAQ:SHOP), Salesforce (NYSE:CRM), Uber Technologies (NYSE:UBER), ServiceNow Inc. (NYSE:NOW), Adobe (NASDAQ:ADBE), Intuit (NASDAQ:INTU), Datadog (NASDAQ:DDOG), Autodesk (NASDAQ:ADSK), Workday (NASDAQ:WDAY), Atlassian Corp (NASDAQ:TEAM).

Industry description

Packaged software comprises multiple software programs bundled together and sold as a group. For example, Microsoft Office includes multiple applications such as Excel, Word, and PowerPoint. In some cases, buying a bundled product is cheaper than purchasing each item individually[s20] . Microsoft Corporation, Oracle Corp. and Adobe are some major American packaged software makers.

Market Cap

The average market capitalization across the Packaged Software Industry is 10.31B. The market cap for tickers in the group ranges from 291 to 240.81B. SAP holds the highest valuation in this group at 240.81B. The lowest valued company is BLGI at 291.

High and low price notable news

The average weekly price growth across all stocks in the Packaged Software Industry was -0%. For the same Industry, the average monthly price growth was 1%, and the average quarterly price growth was 8%. NIQ experienced the highest price growth at 44%, while NXTT experienced the biggest fall at -99%.

Volume

The average weekly volume growth across all stocks in the Packaged Software Industry was -22%. For the same stocks of the Industry, the average monthly volume growth was 4% and the average quarterly volume growth was -61%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 52
P/E Growth Rating: 77
Price Growth Rating: 56
SMR Rating: 78
Profit Risk Rating: 94
Seasonality Score: -2 (-100 ... +100)
View a ticker or compare two or three
ADP
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a provider of business outsourcing solutions

Industry PackagedSoftware

Profile
Details
Industry
Data Processing Services
Address
One ADP Boulevard
Phone
+1 973 974-5000
Employees
64000
Web
https://www.adp.com
Interact to see
Advertisement
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.
Gogo shares continue to trade near 52-week lows around $4, weighed down by competitive threats from Starlink and slower-than-anticipated AVANCE system upgrades. William Blair downgraded the stock to Market Perform in December 2025, citing leverage concerns and intensifying rivalry in in-flight connectivity.
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.